Skip to content
10-Q

Quarterly Report

Imago BioSciences, Inc.

0000950170-22-009736

← back to feed
Filed
May 12, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 5, 2022 33.74M sh
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$11.52M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$7.05M
Short Term Investments Q1 2022 · Mar 31, 2022 $197.56M
Short Term Investments Q1 2022 · Dec 31, 2021 $206.18M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $8.26M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $11.23M
Stockholders Equity Q1 2022 · Mar 31, 2022 $199.51M
Stockholders Equity Q1 2022 · Dec 31, 2021 $214.69M
Stockholders Equity Q1 2022 · Mar 31, 2021 −$75.56M
Stockholders Equity Q1 2022 · Dec 31, 2020 −$68.78M
Current Liabilities Q1 2022 · Mar 31, 2022 $12.93M
Current Liabilities Q1 2022 · Dec 31, 2021 $10.09M
Current Assets Q1 2022 · Mar 31, 2022 $208.98M
Current Assets Q1 2022 · Dec 31, 2021 $221.3M
Total Assets Q1 2022 · Mar 31, 2022 $212.45M
Total Assets Q1 2022 · Dec 31, 2021 $224.79M
Sga Expense Q1 2022 · Mar 31, 2022 $4.01M
Sga Expense Q1 2022 · Mar 31, 2021 $2.38M
Rd Expense Q1 2022 · Mar 31, 2022 $12.5M
Rd Expense Q1 2022 · Mar 31, 2021 $4.77M
Net Income Q1 2022 · Mar 31, 2022 −$16.39M
Net Income Q1 2022 · Mar 31, 2021 −$7.11M
Operating Income Q1 2022 · Mar 31, 2022 −$16.51M
Operating Income Q1 2022 · Mar 31, 2021 −$7.15M